Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Dual sensory impairment in older adults linked to higher risk for dementia

Dual sensory impairment in older adults linked to higher risk for dementia

Scientists receive grant to study cerebrovascular changes during healthy and Alzheimer's aging

Scientists receive grant to study cerebrovascular changes during healthy and Alzheimer's aging

DNA resection pathways are highly specific, shows study

DNA resection pathways are highly specific, shows study

Study shows how non-alcoholic fatty liver disease causes Alzheimer's-like neuroinflammation

Study shows how non-alcoholic fatty liver disease causes Alzheimer's-like neuroinflammation

New treatment approach for Alzheimer's disease

New treatment approach for Alzheimer's disease

Brain imaging can predict cognitive decline in Alzheimer’s disease

Brain imaging can predict cognitive decline in Alzheimer’s disease

Study identifies a promising way to delay the onset of Alzheimer's disease

Study identifies a promising way to delay the onset of Alzheimer's disease

Developing Vaccines and Therapeutics by Exploiting Structure in Spherical Nucleic Acids

Developing Vaccines and Therapeutics by Exploiting Structure in Spherical Nucleic Acids

NIH announces $75 million in funding to improve genomic risk assessments for diverse populations

NIH announces $75 million in funding to improve genomic risk assessments for diverse populations

More than one-third of excess deaths in pandemic's early months linked to other causes

More than one-third of excess deaths in pandemic's early months linked to other causes

CHOP researchers receive multi-million dollar grant to study disease risk in African Americans

CHOP researchers receive multi-million dollar grant to study disease risk in African Americans

Common asthma drug may offer potential as treatment for Alzheimer's disease

Common asthma drug may offer potential as treatment for Alzheimer's disease

Study sheds light on selective neuronal vulnerability in Alzheimer’s disease

Study sheds light on selective neuronal vulnerability in Alzheimer’s disease

Alzheimer’s drug could be re-purposed to reverse blood vessel damage in diabetes

Alzheimer’s drug could be re-purposed to reverse blood vessel damage in diabetes

Research shows how a protein's small change leads to big trouble for cells

Research shows how a protein's small change leads to big trouble for cells

New study will help primary care nurses better care for dementia patients

New study will help primary care nurses better care for dementia patients

Researchers track brain receptor as it transmits or inhibits neural signals

Researchers track brain receptor as it transmits or inhibits neural signals

Salk Institute expands research to find treatments and cures for COVID-19

Salk Institute expands research to find treatments and cures for COVID-19

‘More than physical health’: Gym helps 91-year-old battle isolation

‘More than physical health’: Gym helps 91-year-old battle isolation

Study shows how the brain's auditory system is affected by HIV

Study shows how the brain's auditory system is affected by HIV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.